MYL9 silencing inhibits proliferation and migration of lung adenocarcinoma cells: a potential therapeutic target
Background Myosin light chain 9 (MYL9), a regulatory light chain of myosin II, plays a crucial role in cytoskeletal dynamics and has been associated with tumor progression in multiple malignancies. However, its role in lung adenocarcinoma (LUAD) remains poorly characterized. Despite recent advances in treatment, the pr...